Erythrina senegalensis

Erythrina senegalensis contains bioactive compounds including erysotrine, alkaloids, flavonoids, and tannins that contribute to its antimicrobial activity. These constituents work through multiple mechanisms: disrupting microbial cell membranes, inhibiting bacterial enzyme function, and interfering with pathogen protein synthesis. The tannins provide astringent effects that support wound healing, while flavonoids contribute anti-inflammatory properties. Evidence level: C (preliminary pharmacological studies demonstrate antimicrobial activity in vitro, though human clinical trials remain limited).

Erythrina senegalensis is considered unsafe during pregnancy and should be strictly avoided. The bark contains alkaloids, including erysotrine, which may exert uterine stimulant effects or cause fetal toxicity. Traditional use guidelines explicitly contraindicate this herb for pregnant women. Additionally, the muscle relaxant properties of its alkaloid constituents pose theoretical risks to fetal development. Women who are pregnant, planning pregnancy, or breastfeeding should not use this herb. Evidence level: C (based on constituent toxicity profiles and traditional contraindications).

Traditional adult dosage of Erythrina senegalensis bark is 5-10 grams prepared as a decoction, taken twice daily. For topical application, the bark is ground into a paste and applied directly to affected skin areas for treating skin diseases and infections. Dosage should not exceed recommended amounts due to the herb's cumulative muscle relaxant effects. Evidence level: C (based on traditional use protocols; standardized clinical dosing guidelines have not been established through controlled trials).

Erythrina senegalensis may interact with medications due to its muscle relaxant alkaloids. Caution is warranted when combining with central nervous system depressants, skeletal muscle relaxants, or anesthetic agents, as additive effects may occur. The alkaloids present, including erysotrine, can potentiate muscle relaxation and may enhance sedative effects. Patients taking prescription medications should consult a qualified healthcare provider before using this herb. Evidence level: C (theoretical interactions based on constituent pharmacology; formal interaction studies are lacking).

Erythrina senegalensis bark has been used traditionally across West Africa and the Sahel region to treat skin diseases, bacterial and fungal infections, fever, and venereal diseases. Traditional healers employ both internal preparations (decoctions) and external applications (pastes) depending on the condition being treated. The plant is valued for its broad antimicrobial and anti-inflammatory properties. Evidence level: C (ethnobotanical documentation and preliminary pharmacological studies support traditional antimicrobial claims; human clinical trials are limited).